| Literature DB >> 33508592 |
Firas Hentati1, Claudia I Cabrera2, Brian D'Anza3, Kenneth Rodriguez4.
Abstract
BACKGROUND: The COVID-19 pandemic has forced the rapid integration of telemedicine services across several specialties, especially in Otolaryngology where risk of transmission is very high. Studies before and during the COVID-19 pandemic have shown that Otolaryngology is generally amenable to telemedicine. However, few studies have assessed patient satisfaction with telemedicine during the COVID-19 pandemic, and fewer have focused on patient satisfaction with telehealth in Rhinology.Entities:
Keywords: COVID-19; Clinic; Coronavirus; Out-patient; Rhinology; Satisfaction; Sinusitis; Survey; Telehealth; Telemedicine
Year: 2021 PMID: 33508592 PMCID: PMC7834232 DOI: 10.1016/j.amjoto.2021.102921
Source DB: PubMed Journal: Am J Otolaryngol ISSN: 0196-0709 Impact factor: 1.808
Demographics.
| Factor | Total ( |
|---|---|
| Age, mean ± SD | 51.2 ± 16.0 |
| Gender, No. (%) | |
| Female | 31 (68.9) |
| Male | 14 (31.1) |
| Chief complaint, No. (%) | |
| Chronic sinus problems | 18 (40.0) |
| Nasal congestion | 5 (11.1) |
| Nasal polyps | 4 (8.9) |
| Nasal drainage | 3 (6.7) |
| Cancer | 2 (4.4) |
| Loss of taste | 1 (2.2) |
| Mucosal thickening | 1 (2.2) |
| Fracture | 1 (2.2) |
| Previous nasal endoscopy, No. (%) | |
| Yes | 43 (95.6) |
| No | 2 (4.4) |
| Symptom progression, No. (%) | |
| Improvement | 11 (24.3) |
| Worsening | 10 (22.2) |
| Same | 24 (53.3) |
| Visit result, No. (%) | |
| Steroids prescribed | 12 (26.7) |
| Antibiotics prescribed | 8 (17.8) |
| Saline gels prescribed | 3 (6.7) |
| Anti-histamines prescribed | 1 (2.3) |
| Parasympatholytic prescribed | 1 (2.2) |
| Nasal cones prescribed | 1 (2.2) |
| Surgery scheduled | 6 (13.3) |
| Referral to other provider | 3 (6.7) |
| None | 17 (37.8) |
Overview of participant age, gender distribution as well as primary diagnosis and complaints, symptom progression since prior visit, and visit results including medication prescription and surgery scheduling.
Survey responses.
| Factor | Total ( |
|---|---|
| Have you ever had a virtual visit (a live audio or audio-video interaction with a provider) prior to the coronavirus pandemic (prior to March 15th), No. (%) | |
| Yes | 5 (11.1) |
| No | 40 (88.9) |
| Has the coronavirus pandemic changed your desire to be seen in person by a provider? No. (%) | |
| Yes | 21 (46.7) |
| No | 24 (53.3) |
| Do you think anything was missed or not addressed because you were not seen in person? No. (%) | |
| Yes | 13 (28.9) |
| No | 32 (71.1) |
| Would you do another virtual visit in the future if the pandemic ends and you could be seen face to face in clinic? No. (%) | |
| Yes | 35 (77.8) |
| No | 10 (22.2) |
| Do you prefer the virtual visit experience to being seen in person, assuming the same quality of care? No. (%) | |
| Yes | 17 (37.8) |
| No | 28 (62.2) |
| Do you feel that your needs were met via virtual visit? No. (%) | |
| Yes | 36 (80.0) |
| No | 9 (20.0) |
| Do you feel that communication in your virtual visit was the same, better, or worse compared to being seen in person? No. (%) | |
| Better | 4 (8.9) |
| Worse | 12 (26.7) |
| Same | 29 (64.4) |
Overview of participant responses to close-ended survey questions.
Fig. 1Bar graph of participant responses to survey. Blue bar represents percentage of “yes” answers. Red bars represent percentage of “No” answers. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Advantages, disadvantages, and changes to telemedicine visit.
| Factor | Total ( |
|---|---|
| Advantages to telemedicine visit, No. (%) | |
| Availability of provider | 9 (20.0) |
| Convenience | 10 (22.2) |
| No time off work | 4 (8.9) |
| No travel | 5 (11.1) |
| Time saving | 6 (13.3) |
| Safety | 6 (13.3) |
| Visits not rushed | 2 (4.4) |
| None | 3 (6.7) |
| Disadvantages to telemedicine visit (other than lack of physical exam), No. (%) | |
| Technological difficulties | 8 (17.8) |
| Less personal interaction | 4 (8.9) |
| Poor communication | 2 (4.4) |
| None | 31 (68.9) |
| Changes to telemedicine visit, No. (%) | |
| Lower costs | 1 (2.2) |
| Improved scheduling/coordination | 4 (8.9) |
| Improved technology | 2 (4.4) |
| Incorporation of diagnostic testing | 2 (4.4) |
| None | 36 (80.0) |
Participant survey responses to free response questions on advantages and disadvantages of telemedicine visits, and changes that participants would like to see made to telemedicine coordination.
Fig. 2Responses to free response questions on advantages (A) and disadvantages (B) of telemedicine visits, and changes that participants would like to see made to telemedicine coordination (C).
Survey responses based on change in desire to see provider.
| Factor | Change in desire to see provider | No change in desire to see provider | |
|---|---|---|---|
| Have you ever had a virtual visit (a live audio or audio-video interaction with a provider) prior to the coronavirus pandemic (prior to March 15th) | 0.205 | ||
| Yes | 1(4.7) | 4(16.7) | |
| No | 20(95.2) | 20(83.3) | |
| Do you think anything was missed or not addressed because you were not seen in person? | 0.482 | ||
| Yes | 5 (23.8) | 8 (33.3) | |
| No | 16 (76.2) | 16 (66.7) | |
| Would you do another virtual visit in the future if the pandemic ends and you could be seen face to face in clinic? | 0.055 | ||
| Yes | 19 (90.5) | 16 (66.7) | |
| No | 2 (9.5) | 8 (33.3) | |
| Do you prefer the virtual visit experience to being seen in person, assuming the same quality of care? | 0.002 | ||
| Yes | 13 (61.9) | 4 (16.7) | |
| No | 8 (38.1) | 20 (83.3) | |
| Do you feel that your needs were met via virtual visit? | 0.100 | ||
| Yes | 19 (90.5) | 17 (70.8) | |
| No | 2 (9.5) | 7 (29.2) | |
| Do you feel that communication in your virtual visit was the same, better, or worse compared to being seen in person? | 0.146 | ||
| Better | 3 (14.3) | 1 (4.2) | |
| Worse | 3 (14.3) | 9 (37.5) | |
| Same | 15 (71.4) | 14 (58.3) |
Participant survey response divided by change in desire to see provider.
p-Values signify a 95% confidence interval: calculated with Pearson's Chi-squared.